ARCC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the investor's beginner level, long-term strategy, and available capital, Ares Capital Corp (ARCC) does not present a compelling buy opportunity at this time. The technical indicators are bearish, financial performance shows declining trends, and there are no strong positive catalysts to offset the risks. Holding off on investment until stronger signals emerge is advised.
The technical indicators for ARCC suggest a bearish trend. The MACD is slightly positive but contracting, RSI is neutral at 37.816, and moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock price is below the pivot level of 18.096, with key support at 17.707 and resistance at 18.486.
Insider buying has increased significantly by 165.49% over the last month, which could indicate confidence from management. Additionally, ARCC is mentioned positively in the context of high-yield dividend stocks, which may attract long-term income-focused investors.
The broader private debt market is facing challenges, as highlighted by Moody's downgrade of FS KKR Capital Corp and Apollo's liquidity restrictions. ARCC's financial performance is declining, with YoY drops in revenue (-5.55%), net income (-17.93%), and EPS (-25.45%). Analyst price targets have been lowered by UBS, JPMorgan, and B. Riley, reflecting reduced confidence in the stock.
In Q4 2025, ARCC reported a decline in revenue to $715 million (-5.55% YoY), net income to $293 million (-17.93% YoY), and EPS to 0.41 (-25.45% YoY). Gross margin also dropped to 70.63 (-6.20% YoY), indicating weakening profitability.
Analyst sentiment is mixed to slightly negative. UBS and JPMorgan lowered price targets to $19, citing lower multiples and higher scrutiny in the business development company space. B. Riley reduced the price target to $22 but maintained a Buy rating, reflecting cautious optimism.
